Connect your AI

Eli Lilly LLY Operating Cash Flow

Operating Cash Flow at other companies

PfizerPFE

$2.62B+12.0%

AmgenAMGN

$2.19B+57.4%

Cardinal HealthCAH

$1.82B-37.6%

BiogenBIIB

$645.5M+149%

MannkindMNKD

-$5.37M+15.9%

Oruka Therapeutics, Inc.ORKA

-$23.58M-13.0%

Other financials

Income statement

Revenue$19.8B+55.5%

Gross profit$16.2B+54.4%

Net income$7.4B+168%

EPS (diluted)$8.26+170%

Balance sheet

Cash & equivalents$5.3B+70.8%

Total debt$43.4B+12.6%

Total equity$31.2B+97.9%

Total assets$116.58B+30.4%

Cash flow

CapEx$2.3B+54.0%

Free cash flow$3.0B+1,828%

Valuation

Market cap$1.01T+46.9%

Enterprise value$1.04T+44.9%

P/E39.8×-21.9×

P/S13.9×-0.1×

Profitability

Gross margin82.8%+1.1pp

Net margin35%+12.3pp

FCF margin16.4%+8.7pp

Returns & leverage

Return on equity107.6%+29.9pp

Debt / equity1.4×-1.1×

Current ratio1.5×+0.1×

Where this comes from

Reported directly by Eli Lilly in its filing.

Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities.

The official record: Eli Lilly’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Eli Lilly's operating cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is Eli Lilly's operating cash flow?: Eli Lilly (LLY) reported operating cash flow of $5.33B in Q1 2026.
How has Eli Lilly's operating cash flow changed year-over-year?: Eli Lilly's operating cash flow increased by 220.1% year-over-year, from $1.67B to $5.33B.
What is the long-term trend for Eli Lilly's operating cash flow?: Over 4 years (2021 to 2025), Eli Lilly's operating cash flow has grown at a 22.9% compound annual growth rate (CAGR), from $7.37B to $16.81B.
What does operating cash flow mean?: Total cash generated by or used in core business operations — the single most important cash flow metric for assessing business health.